Arcus Biosciences
Buying intent
15 tracked signals | Top 13 topics are below | Engineering is carrying most of it.
Attention by team
LinkedIn activity, by teamWhere Arcus Biosciences's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
23d ago
17d ago
23d ago
30d ago
30d ago
11d ago
11d ago
26d ago
10d ago
23d ago
23d ago
23d ago
26d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Arcus Biosciences
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
Primary products / business lines
LinkedIn company profileArcus Biosciences is a rapidly growing, clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines that may have the potential to help people with cancer live longer. Located in the San Francisco bay area, Arcus Biosciences offers a competitive compensation and benefits package, including aggressive participation in the growth of the company in
Top accounts researching Arcus Biosciences
names withheld on the public pageThese are companies whose own people brought up Arcus Biosciences unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
3,463 companies · 13,523 people are researching Clinical Trials
Arcus Biosciences's own team shows 2 signals on this topic. No one outside Arcus Biosciences has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Pharmaceutical5,568 cos · 20,395 people
- Issue Management118 cos · 305 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Finance — 1 person; Engineering — 1 person
What's been said
public posts by Arcus Biosciences's teamNo public post naming Arcus Biosciences has surfaced in the past year, so this is what Arcus Biosciences's own team is posting about publicly — their topics, in their words.
Good Morning Everyone, I know this is a quick due out; however, I wanted to post for reach. Greetings from the Center for Enhanced Performance at West Point! I’m reaching out today to announce that we are now seeking qualified applicants for our Fall 2026 internship. Please see the attached flyer for more details about this internship opportunity. If interested, please apply by sending an email containing a cover letter and your resume, using the subject line “CEP Internship Application” to matthew.gonzalez@westpoint.edu . This Fall 2026 internship will begin approximately on August 12th, 2026 and end approximately on December 11th, 2026. Please note that for applications to be considered they must be submitted by close of business on April 17th, 2026. If you have any questions, please feel free to email me backchannel. Have a great day and please pass this along to anyone you feel might be interested! Kind regards, Doc Shelly
Apr 2026Strategic priorities
Earnings call; SEC filingsFrontLine; Portfolio+; Competitive Advantage
What changed recently
Earnings call; SEC filingsFrontLine; Portfolio+; Competitive Advantage